Identification and characterization of receptor-interacting protein 2 as a TNFR-associated factor 3 binding partner

Gene

Volumn 517, Issue 2, 2013, Pages 205-211

  Cai, Xin ^a   Du, Jianfang ^a   Liu, Ye ^a   Xia, Wengrong ^a   Liu, Jing ^b   Zou, Minji ^a   Wang, Yuanyuan ^a   Wang, Min ^a   Su, Hang ^b   Xu, Donggang ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Interaction; Ramos cells; RIP2; TRAF3; Two hybrid

Indexed keywords

GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOMA CELL LINE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SPLEEN; TWO HYBRID SYSTEM; YEAST CELL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENE KNOCKDOWN TECHNIQUES; GENE LIBRARY; HEK293 CELLS; HUMANS; NF-KAPPA B; PROTEIN INTERACTION MAPS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SIGNAL TRANSDUCTION; SPLEEN; TNF RECEPTOR-ASSOCIATED FACTOR 3; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 84873749310     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.026     Document Type: Article

References (38)

1. Bertrand M.J., Doiron K., Labbe K., Korneluk R.G., Barker P.A., Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 2009, 30:789-801.
2. Bishop G.A., Xie P. Multiple roles of TRAF3 signaling in lymphocyte function. Immunol. Res. 2007, 39:22-32.
3. Cheng G., Cleary A.M., Ye Z., Hong D.I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 1995, 267:1494-1498.
4. Chin A.I., Dempsey P.W., Bruhn K., Miller J.F., Xu Y., Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002, 416:190-194.
5. Engidawork E., Gulesserian T., Yoo B.C., Cairns N., Lubec G. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 2001, 281:84-93.
6. Gardam S., Sierro F., Basten A., Mackay F., Brink R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 2008, 28:391-401.
7. Gulesserian T., Engidawork E., Yoo B.C., Cairns N., Lubec G. Alteration of caspases and other apoptosis regulatory proteins in down syndrome. J. Neural Transm. Suppl. 2001, 61:163-179.
8. Häcker H., et al. Specificity in TLR signaling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439:204-207.
9. Häcker H., Tseng P.H., Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 2011, 11:457-468.
10. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
11. Hildebrand J.M., Yi Z., Buchta C.M. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions. Immunology 2011, 244:55-74.
12. Hu H.M., O'Rourke K., Boguski M.S., Dixit V.M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 1994, 269:30069-30072.
13. Inohara N., del Peso L., Koseki T., Chen S., Nunez G. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 1998, 273:12296-12300.
14. Kalkoff M., Cursons R.T., Sleigh J.W., Jacobson G.M. The use of real time rtPCR to quantify inflammatory mediator expression in leukocytes from patients with severe sepsis. Anaesth. Intensive Care 2004, 32:746-755.
15. Kobayashi K., et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416:194-199.
16. Krieg A., et al. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14524-14529.
17. Liao G., Zhang M., Harhaj E.W., Sun S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 2004, 279:26243-26250.
18. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2002, 2:465-475.
19. Marsters S.A., Yan M., Pitti R.M., Haas P.E., Dixit V.M., Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 2000, 10:785-788.
20. Matsuzawa A., et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 2008, 321:663-668.
21. McCarthy J.V., Ni J., Dixit V.M. RIP2 is a novel NF-kappaB activating and cell death-inducing kinase. J. Biol. Chem. 1998, 273:16968-16975.
22. Oganesyan G., et al. Critical role of TRAF3 in the TLR-dependent and independent antiviral response. Nature 2006, 439:208-211.
23. Pham L.V., et al. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways. Blood 2011, 117:200-210.
24. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor. Cell 1994, 78:681-692.
25. Saha S.K., Cheng G. TRAF3: a new regulator of type I interferons. Cell Cycle 2006, 5:804-807.
26. Schneider P., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 1999, 189:1747-1756.
27. Solan N.J., Miyoshi H., Carmona E.M., Bren G.D., Paya C.V. RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 2002, 277:1405-1418.
28. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006, 6:9-21.
29. Sun S.C. Non-canonical NF-κB signaling pathway. Cell Res. 2011, 21:71-85.
30. Thome M., et al. Identification of CARDIAK, a RIP like kinase that associates with caspase-1. Curr. Biol. 1998, 8:885-888.
31. Thompson J.S., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001, 293:2108-2111.
32. Tseng P.H., Matsuzawa A., Zhang W., Mino T., Vignali D.A., Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 2010, 11:70-75.
33. Vallabhapurapu S., Karin M. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
34. Vallabhapurapu S., et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kB signaling. Nat. Immunol. 2008, 9:1364-1370.
35. Wang X., et al. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. J. Neurosci. 2005, 25:11645-11654.
36. Xiao G., Fong A., Sun S.C. Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J. Biol. Chem. 2004, 279:30099-30105.
37. Xie P., Kraus Z.J., Stunz L.L., Liu Y., Bishop G.A. TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling. J. Immunol. 2011, 186:143-155.
38. Zarnegar B.J., et al. Non-canonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 2008, 9:1371-1378.